# Evaluate: Pharma commercial intelligence, news \& analysis > Trusted commercial intelligence, consensus forecasts, news and analysis for pharma, biotech and medtech industry \- Explore Evaluate Generated by Yoast SEO v27.5, this is an llms.txt file, meant for consumption by LLMs. ## Pages - [About](https://www.evaluate.com/about/) - [Contact](https://www.evaluate.com/contact/) - [Resources](https://www.evaluate.com/resources/) - [Webinars](https://www.evaluate.com/webinars/) - [Thought Leadership](https://www.evaluate.com/thought-leadership/) - [Evaluate Pharma](https://www.evaluate.com/solutions/evaluate-pharma/): Effective forecasting stands as a cornerstone for pharmaceutical and biotechnology enterprises, shaping strategies, mitigating risks, and propelling innovation forward\. Elevate your decision\-making with Evaluate Pharma, the premier destination for consensus forecasts trusted by pharmaceutical firms, investment banks, and consultancies alike\. - [Solutions](https://www.evaluate.com/solutions/) - [How We Help](https://www.evaluate.com/how-we-help/) - [Consulting](https://www.evaluate.com/consulting/) - [Content Hubs](https://www.evaluate.com/content-hubs/) - [Biomedtracker](https://www.evaluate.com/solutions/biomedtracker/) - [Datamonitor Healthcare](https://www.evaluate.com/solutions/datamonitor-healthcare/) - [Evaluate Medtech](https://www.evaluate.com/solutions/evaluate-medtech/): Utilize Evaluate Medtech to swiftly gauge market perceptions of your company and product portfolio, as well as those of your competitors, clients, and potential new business partners\. - [World Preview Content Hub](https://www.evaluate.com/content-hubs/world-preview/) - [\#JPM2026 Content Hub](https://www.evaluate.com/content-hubs/jpm2026/) ## Posts - [BIO‑Europe Spring出展報告:リスボンで注目を浴びたディールメイキングから](https://www.evaluate.com/blog/bio-europe-spring-pharma-dealmaking-in-lisbon/) - [製品ライフサイクルに応じて変化する製薬業界の売上予測アプローチ(所要時間3分)](https://www.evaluate.com/video-blog/forecasting-through-the-pharma-product-lifecycle/) - [A Clearer View from JPM 2026 – Day Four](https://www.evaluate.com/blog/a-clearer-view-from-jpm-2026-day-four/) - [Highlights of the Orphan Drugs Report by its Creators](https://www.evaluate.com/video-blog/orphan-drugs-report-highlights-authors/) - [How do Forecasting Approaches and Methodologies Change Through the Product Lifecycle?](https://www.evaluate.com/video-blog/forecasting-through-the-pharma-product-lifecycle/) ## Disease Reports - [Prostate Cancer Report](https://www.evaluate.com/disease-report/prostate-cancer-report/) - [Multiple Myeloma Report](https://www.evaluate.com/disease-report/multiple-myeloma/) - [Bladder Cancer Report](https://www.evaluate.com/disease-report/bladder-cancer-report/) - [Chronic Heart Failure Report](https://www.evaluate.com/disease-report/chronic-heart-failure-report/) - [Sjogren's Disease Report](https://www.evaluate.com/disease-report/sjogrens-disease-report/) ## Events - [CPHI2026特設ページ│不確実な市場で、 ​確かな戦略を](https://www.evaluate.com/event/cphi-2026/) - [Evaluate Financing Forum: Biotech Strategies for Accessing Capital](https://www.evaluate.com/event/evaluate-financing-forum/) - [Bio Europe](https://www.evaluate.com/event/bio-europe/) - [Pharma CI Europe](https://www.evaluate.com/event/pharma-ci-europe/) - [BIO International](https://www.evaluate.com/event/bio-international/) ## Interviews - [Ryan Lu: Mapping the Development Landscape](https://www.evaluate.com/interview/mapping-the-development-landscape-ryan-lu/) - [Finding her niche in forecasting — and finding answers for clients](https://www.evaluate.com/interview/expert-interview-sheila-li-pharma-forecasting/) - [Plethora of Data Creates Demand for Competitive Intelligence](https://www.evaluate.com/interview/pharma-competitive-intelligence-data-advantage/) - [Competitive Intelligence in Pharma](https://www.evaluate.com/interview/consultant-insights-competitive-intelligence-pharma/) - [Providing unbiased pharma market research to inform business decisions](https://www.evaluate.com/interview/unbiased-pharma-market-research-expert-interview/) ## Leaderships - [パイプライン競争や特許満了を乗り越える、売上予測戦略レポート](https://www.evaluate.com/thought-leadership/future-ready-forecasting-for-pharma/): \特許満了(LoE)は製薬業界全体に急速な変化をもたらし、数十億ドル規模の売上がリスクにさらされる中、従来の売上予測の限界が試されています。\ \\ パテントクリフが迫る中、売上予測チームには、単なる売上減少の予測にとどまらず、競合品の参入、価格下落圧力、そしてその影響を緩和するための戦略までを織り込んだモデル構築が求められています。\\本レポートでは、ライフサイクルの短期化が進む環境において、ポートフォリオ価値を守るために、シナリオドリブンな高度な売上予測がいかに戦略的に不可欠な存在となっているかを詳しく解説します。 - [2025年製薬業界ディールメイキング総括 サマリ版](https://www.evaluate.com/thought-leadership/2025-deal-making-roundup-infographic/): 2025年、バイオファーマのディールメイキングは力強く回復しました。信頼感の高まり、大型取引の増加、そしてアライアンス価値の過去最高更新が、この1年を特徴づけています。最新のDeal‑making Roundupでは、特に重要となった主要数値、トレンド、治療領域の注力分野をまとめています。 - [Medtech World Preview 2022: Back to Reality Infographic](https://www.evaluate.com/thought-leadership/medtech-world-preview-2022-back-reality-infographic/) - [Medtech World Preview 2022: Back to Reality Report](https://www.evaluate.com/thought-leadership/medtech-world-preview-2022-back-to-reality-report/) - [World Preview 2022 Infographic](https://www.evaluate.com/thought-leadership/world-preview-2022-infographic/) ## Press Release - [サイトライン/エバリュエート、CPHI Japan 2026 に出展](https://www.evaluate.com/press-release/cphi-2026/) - [Norstella Appoints Kris Joshi as Chief Executive Officer](https://www.evaluate.com/press-release/kris-joshi-norstella-ceo/) - [Evaluate Releases 2026 Orphan Drug Report](https://www.evaluate.com/press-release/2026-orphan-drug-report/) - [Evaluate Releases 2030 Forecasts for Global Pharmaceutical Market](https://www.evaluate.com/press-release/evaluate-releases-2030-forecasts-for-global-pharmaceutical-market/) - [Norstella Appoints Kris Joshi as Chief Executive Officer](https://www.evaluate.com/press-release/kris-joshi-norstella-ceo/) ## Webinars - [World Preview 2024: Pharma's Growth Boost \- On Demand Webinar](https://www.evaluate.com/webinar/world-preview-2024-pharmas-growth-boost-on-demand/) - [2025 World Preview: Turbulent Seas](https://www.evaluate.com/webinar/turbulent-seas-2025-world-preview/) - [韓国バイオの大躍進―新薬開発動向、提携トレンド、政府による支援を現地記者が徹底解説](https://www.evaluate.com/webinar/scrip-korea-webinar/) - [希少疾患開発大解剖―地政学・規制リスク時代における次の一手とは](https://www.evaluate.com/webinar/orphan-drug-2026/) - [2024 Preview Webinar: Will Biopharma Find its Footing?](https://www.evaluate.com/webinar/2024-preview-webinar-will-biopharma-find-footing/) ## Categories - [Blog](https://www.evaluate.com/category/blog/) - [Report/eBook](https://www.evaluate.com/category/report-ebook/) - [Webinar](https://www.evaluate.com/category/webinar/) - [Infographic](https://www.evaluate.com/category/infographic/) - [Article](https://www.evaluate.com/category/article/) ## Tags - [Forecasts \& Market Landscape](https://www.evaluate.com/tag/forecasts-market-landscape/) - [Strategy \& Commercial](https://www.evaluate.com/tag/strategy-and-commericial/) - [Dealmaking](https://www.evaluate.com/tag/dealmaking/) - [Resource Form](https://www.evaluate.com/tag/resource-form/) - [Finance \& Investment](https://www.evaluate.com/tag/finance-investment/) ## Optional - [Sitemap index](https://www.evaluate.com/sitemap_index.xml)